Advair

DRUG3 trials

Sponsors

University of British Columbia, Teva Branded Pharmaceutical Products R&D, Inc., Johns Hopkins University

Conditions

AsthmaChronic Obstructive Pulmonary Disease

Phase 4

Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial

University of British ColumbiaChronic Obstructive Pulmonary Disease

Start: 2004-12-31End: 2006-08-31Target: 250Updated: 2006-05-09

Non-invasive Measures of Distal Lung Disease in Asthmatics

CompletedNCT00250341

Teva Branded Pharmaceutical Products R&D, Inc.Asthma

Start: 2005-09-30End: 2007-09-30Target: 34Updated: 2021-12-02

A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma

TerminatedNCT00461812

Johns Hopkins UniversityAsthma

Start: 2007-04-30End: 2010-01-19Updated: 2017-09-20